{
    "organizations": [],
    "uuid": "e4e0ef6f43a4a1a090e98da1014f0f7468af9558",
    "author": "",
    "url": "https://www.reuters.com/article/brief-us-fda-approved-aimovig-for-preven/brief-u-s-fda-approved-aimovig-for-preventive-treatment-of-migraine-in-adult-idUSFWN1SO0Z9",
    "ord_in_thread": 0,
    "title": "BRIEF-US FDA Approved Aimovig For Preventive Treatment Of Migraine In Adult - Reuters",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) -\n* U.S. FDA APPROVES NOVEL PREVENTIVE TREATMENT FOR MIGRAINE\n* U.S. FDA SAYS IT GRANTED THE APPROVAL OF AIMOVIG TO AMGEN INC\n* U.S. FDA APPROVED AIMOVIG (ERENUMAB-AOOE) FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULT Further company coverage:\n ",
    "published": "2018-05-18T02:04:00.000+03:00",
    "crawled": "2018-05-18T03:06:29.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "fda",
        "approves",
        "novel",
        "preventive",
        "treatment",
        "migraine",
        "fda",
        "say",
        "granted",
        "approval",
        "aimovig",
        "amgen",
        "inc",
        "fda",
        "approved",
        "aimovig",
        "preventive",
        "treatment",
        "migraine",
        "adult",
        "company",
        "coverage"
    ]
}